Peto test procedures for the statistical evaluation of carcinogenicity studies require that each tumor in an animal that died intercurrently (or was sacrificed in exfreniis) be classified as either fatal, probably fatal, incidental, or probably incidental. There is considerable controversy as to whether or not the cause of death can be established with accuracy in rodent studies. In the present article, the causes of death or ill-being as found in 10 consecutive carcinogenicity studies-5 studies with 2400 OFA (Sprague-Dawley-derived) and Wistar rats and 5 studies with 2400 OF1 and NMRI mice-were re-examined. A cause of death or moribund state had been established in more than 80% of the cases in rats and in more than 70% in mice. These causes were, in rats, mainly pituitary tumors, chronic progressive nephropathy (males), mammary gland tumors (females), and subcutaneous tumors (males); in mice, mainly hemolymphoreticular tumors, lung tumors, liver tumors (males), and glomerulonephropathy. The criteria used for determining the tumorous or nontumorous lesions as the cause of death were based on in-life and pathological findings. The validity of such procedures, the possibility of improving criteria in the future, and the usefulness of establishing causes of death in safety assessment are discussed.
INTRODUCTION
The incidence of spontaneous and generally also of drug-induced lesions and tumors in rodents increases with age (1, 3, 9) , whereas resistance to transplanted tumors or injected tumor cells generally decreases with increasing age (1). Therefore, age and time at study are important variables to be considered in the evaluation of a carcinogenicity study (5, 11) . The chances of developing age-related lesions are obviously lower if animals die early during a study. These factors may affect the interpretation of lifetime studies, particularly if there is a treatmentrelated effect (either a shortening or prolonging) on survival.
The Pet0 test (19) and other statistical surviv% adjusted test procedures [for a brief overview, see Haseman (1 I)] require that the relationship between each tumor in an animal that died intercurrently (or was sacrificed in extrentis) and its death (or ill-being, be classified as either fatal, probably fatal, incidental, or probably incidental (context of observation). The choice of an appropriate method to adjust incidence figures for survival depends on whether the tumor of interest is fatal or incidental (19) . This distinction is essential to differentiate between chemicals that reduce survival by shortening the time to iumor onset or the time to death following tumor onset (a true carcinogenic effect) and those .that reduce survival for other reasons including toxicity. In the latter case, tumors are observed earlier simply because the animals concerned are dying of competing causes not necessarily related to carcinogenicity. elso, Kodell et a1 (14) showed that the cause-ofdeath assignment influences the time-to-tumor analysis in carcinogenicity studies. However, not all statistical procedures require cause-of-death data (4).
There is considerable controversy among toxicologic pathologists as to whether o r not the cause of death of an individual animal in toxicity and carcinogenicity studies can be established with accuracy. Basically similar problems, although usually minor ones, also exist in human pathology for determining causes of death (21) . This article deals with the following aspects, among others: 0 The percentages of animals that died or were sacrificed in extreritis during the various studies investigated. 0 Neoplastic and non-neoplastic causes of death. 0 Parameters characterizing the common causes of death of aging rodents in carcinogenicity studies, such as tumor size or age of animals.
TOXICOLOGIC PATHOLOGY
MATERIAL AND METHODS The causes of death or ill-being of animals sacrificed during a study as found in 10 consecutive carcinogenicity studies ( 5 rat studies and 5 mice studies) were re-examined (Tables I and IX). The only relevant treatment-related effects had been a decreased incidence of pituitary tumors in rat study B with a dopaminergic compound and a moderately increased incidence of hemolymphoreticular tumors in mouse study A with an immunosuppressive drug. These treatment-related tumors did not differ morphologically from the spontaneous, age-related tumors.
The animals used (OFA-Sandoz and KfM-Wistar rats, OFA-Sandoz and NMRI mice) were of SPF quality, kept under optimal hygienic conditions, and fed standard laboratory diets. The studies had been run and evaluated in-house with the following ex-ceptions: rat and mouse studies E had been run in a nearby contract laboratory, which used the same strain of animals fromghe same breeder as had been used for the in-house studies. Rat study C was evaluated by a nearby contract pathologist. All studies had been peer-reviewed by one of the present authors (DEP).
The term "intercurrent deaths" was used for animals that had been found dead or sacrificed irt extreniis during a study. The criteria used for designating tumorous or nontumorous lesions as causes of death were based on in-life and pathological findings. These criteria had been established over many years and were refined during the run of this study (see the Appendix).
Causes of death had been determined by the original study pathologist. Data evaluated in this article were collected from written raw data and the study reports. However, in cases of doubt concerning interpretation of the data, the original slides were reexamined. When a tumor was designated as fatal, the lesion was regarded as being directly or indirectly responsible for the animal's death. When a tumor had been described as incidental, the lesion observed was judged not to have caused death and death had arisen from an unrelated cause. No distinction was made between probably fatal and fatal, on the one hand, and probably incidental and incidental, on the other.
-
RESULTS

Rat Carciitogeizicity Studies
A cause of death or moribund state had been established in 83.3% of all cases (Table 11) . Tumors had accounted for 62.9% of intercurrent deaths, nontumorous lesions for 20.4%. On the average, pituitary tumors had been found to be the most frequent causes of death or ill-being for males (36.3% of the cases with a clear cause of death) and females (54.loh), followed by chronic progressive nephropai'hy in males (26.6%), mammary gland tumors in females (1 7.2%), and mostly malignant subcutaneous tumors in males (10.4Yo) (Tables I11 and VII) .
The pituitary tumors (Table IIIa, b) had been, with rare exceptions, adenomas of the pars distalis. Carcinomas of the adenohypophysis had been seen in only 8 females. The mammary gland tumors had mostly been fibroadenomas. "Skin" tumors had been the most heterogeneous group and had comprised lipomas, fibromas, different types of sarcomas and carcinomas, keratoacanthomas, and melanomas. The other neoplastic lesions encountered had been of diverse type.
The mean diameter of the fatal pituitary tumors had been over 7 mm, whereas the cutaneous/subcutaneous tumors, which had severely impaired or killed the rats, had generally measured over 3 cm in diameter (Table IVa, b). Mammary gland tumors had tended to become large and often measured 6 or more cm in diameter at death or sacrifice iri extrernis.
Rats that had died or been sacrificed in extreniis because of tumors had mostly been older than 60 wk of age (Table Va, b) . The interval between clinical manifestation of malignant cutaneous/subcutaneous tumors and death had often only been a few weeks, whereas the interval had tended to be longer for tumors with a morphological benign appearance (Table VIa, b) . No such differences had been observed between mammary gland tumors classified histologically as benign or malignant. Mammary gland tumors had often been present for months before finally killing the animal or necessitating euthanasia.
The most frequent non-neoplastic lesion leading to ill-being or death ofthe animals had been chronic progressive nephropathy (CPN ; Table VII ). CPN had been found to be a typical disease of males. Other non-neoplastic causes of death such as polyarteritis or uterine diseases had occurred only in single studies. CPN had clearly shown itself to be.a disease of old animals, and deaths related to CPN had most frequently been noted toward the end of the animals' life-span (Table VIII) .
Moiise Carciriogeriicity Studies
A cause of death or moribund state had been established in 72.6% of all cases (Table X) . Tumors had accounted for 52% of intercurrent deaths, and nontumorous lesions for 20.6%. On the average, hemolymphoreticular (HLR) tumors had been found to be tl$ most frequent causes of death or ill-being of males (31.5% of the cases with clear cause of death) and females (52.6%>, followed by lung tumors in males (18.69'0) and females (4.79'0) and chronic glomerulopathy (CGP) in males (13.0%) and fe- " Only calculated for 3 and more cases.
ETTLIN ET AL TOXICOLOGIC PATHOLOGY
males (1 4.9%). Liver tumors in males (1 0.1%) and ulcerative skin lesions in males (3.6%) and females (7.2%) had been less frequent (Tables XI and XV) . Eleven benign tumors, ofwhich 7 had been pituitary adenomas and 2 intestinal adenomas, are not shown in Table XI . Fatal HLR tumors had mainly been classified as malignant lymphomas (lymphocytic, lymphoblastic, follicular center cell, immunoblastic, NOS) and, less frequently, as histiocytic sarcomas. Fatal liver and lung tumors had mainly been hepatocellular carcinomas and adenocarcinomas, respectively. The group "other tumors" mainly consisted of soft tissue tumors in male mice and, in female mice, mainly of malignant mammary gland tumors (for incidences of malignant mammary gland tumors see Table XII ). The mean diameters of fatal liver tumors in the 5 studies had ranged between 12.2 and 16.0 mm, and those of lung tumors between 5.2 and 12.5 mm (Table XII) . The diameters of mammary gland tumors that had severely impaired or killed the female mice had been between 15 and 32 mm ( Table XII) .
Mice that had died or been sacrificed in extreriiis because of tumors had generally been older than 1 yr of age (Table XIII) . However, a few mice had died or been sacrificed because of HLR tumors as young as 13 wk of age, because of lung carcinomas as young as 32 wk of age, and because of mammary gland carcinomas as young as 51 wk of age. The average ages at the time of unscheduled death had been lower in study A, which had been terminated in study week 79 according to the practice of the period, whereas the later studies had continued for 75.0 f 19.4
(5 5-1 00) (n = 5) as long as possible (females: wk 91-95; males: wk 101-109; Table IX) . Table XIVa provides an impression of the spread offatal HLR tumors. Considerable variability of the number of involved organs is evident among studies. The group of animals with 6-10 organs infiltrated by HLR tumor cells had tended to be the largest group. The lymphoreticular organs (lymph nodes, thymus, and spleen) had contained HLR tumor cells in 60% or more of the HLR tumor cases (Table XIVb) . Lungs and livers had been infiltrated in at least 40% of the cases; kidneys, reproductive organs, and pancreases in at least 20% of the cases. The sex of the animals had not seemed to influence the distribution pattern of HLR tumor cell infiltration.
The most frequent non-neoplastic lesion leading to ill-being or death of the test mice had been CGP (Table XV) . CGP had affected males and females to a similar extent, in contrast to CPN in rats. U1ceration of the skin had caused unscheduled deaths in only a few mice, which had been housed singly. Females had been affected slightly more often. The reason for the relatively high portion of study D females that had died or been sacrificed due to skin ulcerations is not known. CGP had sometimes been found in relatively young animals; the youngest animal with CGP leading to death had only been 14 wk of age (Table XVI) . This had been in contrast to CPN in rats, which had been fatal only toward the end of the animals' life-span. Skin ulceration had occurred in animals of all ages, with the exception of very young mice (Table XVIIa) . The size'of fatal skin ulcerations was only available for studies D and E (Table XVIIb) . The smallest lesion had measured 6 mm, the largest 28 mm; the average sizes had been between 1 1.7 and 19.4 mm. DISCUSSION AND CONCLUSIONS Neoplastic and non-neoplastic lesions are considered fatal if they compromise vital functions. Thercfore, the decision as to whether certain lesions cause death or not must rely heavily on 2 phases: preterminal clinical observations and all postmortem observations.
The "in-life" observations (including clinical signs, body weight, and palpable mass measurements) can give valuable informatiog on what the pathological process underlying ill-being or unscheduled death might have been. The in-life and macro-and microscopic observations can then be linked to determine the cause or most probable cause of death.
The biological behavior (e.g., invasion, metastases, systemic occurrence) of tumors, the activity of endocrine tumors, and the functional effects of spaceoccupy$g tumors, particularly of central nervous system tumors, must be taken into account by the pathologist in determining the cause of death. The benign pituitary tumors are, because of cerebral compression, generally rapidly fatal. Unfortunately, often little is known about tumor invasiveness and occurrence of metastases. Both parameters are difficult to assess because of the small size of the animals and limited histopathological tissue sampling.
The extent OF dissemination of systemic tumors, particularly of the HLR tumors of mice, is generally better characterized.
Similarly, the detection of nontumorous causes of death depends on a thorough knowledge of systemic pathology in rodents. These lesions, such as age-related kidney and vascular changes, are generally diffuse, and their rating with regard to severity is more difficult than for tumors that are classifiable according to their morphology and size. TOXICOLOGIC PATHOLOGY Causes of death in carcinogenicity studies are mainly due to age-related, well-characterized nontumorous and tumorous lesions. Many laboratories have considerable experience with such lesions and have started to share this experience (1 8). This should facilitate the process of reaching agreement on criteria to classify age-related lesions as fatal or incidental. This may be more difficult for toxic lesions, which are generally diffuse and must be graded on the basis of often highly subjective and study-specific criteria. The present authors did not attempt to establish cause-of-death criteria for toxic lesions because, in their material, deaths during toxicity studies of up to 1 yr duration are relatively rare.
The present criteria for determining the frequent causes of death in carcinogenicity studies had made it possible to establish the cause of death in more than 70% (mice) and 80% (rats) of the cases in the studies examined. The frequency of the various causes of death reflects to some degree the overall incidences of the particular neoplastic and non-neoplastic diseases in the rodent strains used by the present authors (data not shown) and in other rodent strains (2, 3, 13 ). However, experience has shown that many nontumorous lesions and many tumors, although sometimes appearing significant in terms of organ/system lesions, do not cause death in all animals. This holds true for the following: extensive, yet not final, stages of rat CPN; the frequent rodent liver adenomas and cholangiomas; rodent sex cord stromal tumors; rat adrenal cortical and medullary tumors; rat pancreatic acinar and islet cell adenomas; rat thyroid and parathyroid tumors; mouse adrenal cortical tumors; mouse Harderian gland adenomas; and mouse pulmonary adenomas. Nonfatal tumors, however, are often fortuitous findings during microscopic examination and are therefore relatively small. The question remains open as to whether or not such tumors would have become fatal had the animal not died for other reasons including scheduled death. Few data have been published in the past on the causes of death in long-term animal studies. An overview can be found in the monograph concerning principles of toxicologic pathology by Glaister (9) . However, no definitions of the criteria for assessing the fatality of legons are given. Most published data present lesion incidences without addressing the issue of causes of death or without defining the criteria for leth91 diseases (1 2, 17). Unfortunately, the National Toxicology Program Historical Control Data Base does not contain information on causes of death TABL~ IX-The 5 moyse carcinogenicity studies evaluated. either (20), although retrospective studies including cause-of-death assessment have been conducted (1 0). Madison et a1 (1 6) reported the following causes of death in 2,928 untreated BALBkCr mice: 28.7% of the mice had died before the scheduled termination period of 18 mo. Of these, 50.2% had had pneumonia; lung tumors had been observed in 6.5% of the cases, HLR neoplasm in 2.8%, and other solid tumors in 1.5%. Pneumonia has been an infrequent cause of death in mice used by the present authors, probably reflecting the better quality of animals available nowadays and the more hygienic husbandry conditions. In the mouse studies reported in this article, neoplastic lesions had been significantly more frequent than in those reported by Madison et a1 (1 6). As this has also held true for study A, which had been of the same duration as those reported by Madison et al, this higher tumor incidence may have been related to strain differences as well as to differences in longevity and diagnostic criteria for tumors. Maita et a1 (17) published data about the major causes of death or morbidity reported in 11 2-yr carcinogenicity studies with CD-I mice. The most frequent conditions, for both males and females, had been systemic arteritis (observed in more than 3 organs), systemic amyloidosis, auricular thrombosis, CPN, HLR, and lung tumors. In addition, hepatocellular carcinomas in males and mammary gland adenocarcinomas in females had also been critical lesions. While the tumor findings and the occurrence of CGP [called chronic progressive nephropathy by Maita et a1 (17) ] had corresponded to those reported in this article, systemic arteritis and amyloidosis had been of minor importance in the animals used by the authors of the present article.
Numbers of Animals
The variations in the incidence of causes of death or ill-being among the 5 studies examined may have been due in part to study duration and strain of rats (study A versus other studies B-E) as well as to variations in the quality (e.g., in the microbiological status) ofthe animals even ifobtained from thesame breeder (studies RE). Sources of further variation could have been differences in the histopathological terminology of different pathologists as well as varying pathological diagnoses over time. Peer-reviewing as practiced for all studies reported in this article could decrease but not completely eliminate such variations. Marked variability of tumor incidences in the same strain ofrats kept in the same laboratory had also been observed by others (1 7) and had been considered to reflect, in part, biological variability An absessment of the time between onset of the lesion and death from the same lesion had only been possible for skin (subcutaneous) and mammary gland tumors. It had generally been in the order of several months. Kodell et a1 (1 5) estimated the median times (2). to death after appearance of 2-acetylaminofluoreneinduced tumors as follows: bladder neoplasm, 6.8 mo; liver neoplasm, 5.7 mo; and reticulum cell sarcoma, 3.0 mo. The typical age-related tumorous and nontumorous lesions had developed into significant diseases only in old rats, whereas mice had tended to show lesions somewhat earlier.' A few HLR tumors and mammary gland tumors as well as CGP had also been seen in young mice sacrificed irt extretnis or found dead during the first half year of the study.
The size of those tumors considered fatal had depended, not surprisingly, on their location. Pituitary tumors as small as 5 mm had occasionally been found to kill rats, whereas tumors of the internal organs had generally grown to a larger size before becoming fatal, and integumental tumors including mammary gland tumors had become extremely large before they had caused death in an animal. Burek (3) also found that growing pituitary tumors rapidly result in death. Spreading of HLR tumors is obviously not the only parameter to be considered when determining whether or not a HLR tumor had caused death in a mouse. Fatal HLR tumors sometimes affect only a single or a few organs, in particular the lymphoreticular organs as well as lungs, livers, or kidneys.
Tumors, in particular central nervous system tumors including pituitary tumors, can cause death because they compress vital organs. Skin tumors, including mammary gland tumors, can impede feeding and/or cause death by causing local complications such as ulceration and inflammation. Other tumors, particularly malignant and systemic ones, may cause death by invasion of, and occasionally by metastases to, vital organs. Kidney lesions can result in kidney failure, polyarteritis in infarction and bleeding, and lung tumors in respiratory failure. Very often, however, none of these mechanisms is apparent, and it has to be assumed that such tumors cause death by disturbance of the "milieu interieur," that is, of endocrine and/or metabolic regulation. Svaninger et a1 (25) found that nonmetastasizing sarcoma-bearing mice ultimately died from hypoglycemia.
How accurately can causes of death be established? This certainly depends on how carefully animals are observed, particularly during their final life phase, and how carefully the macroscopic examination and tissue sampling are performed. Not surprisingly, the frequency of unknown causes of death had been somewhat higher in mice than in rats, most likely because in-life and necropsy macroscopic inspections are less, accurate in small mice than in the larger rats. The occurrence of several possibly lethal diseases could confound the causeof-death assessment (23) . The instances where 2 or more equally likely causes ofdeath had been present were, however, relatively rare in the 10 studies evaluated. To refine the system, Kodell et a1 (14) suggested distinguishing between euthanasia because of ill-being (cause of moribundity) and death due to a particular lesion. These authors also proposed distinguishing among primary cause of death, cause contributing to death, and equivocal cause of death, as is routinely done during human necropsies (22) . However, for statistical analysis, it is recommended to combine causes of moribundity and of death.
Human death registers appear more reliable than cause-of-death assignments in animal studies because of the extensive examinations performed on patients and because biologically relevant human lesions are significantly larger and therefore easier to detect at necropsy than those of small animals. Metastases of malignant tumors are regularly found in humans but only occasionally in rodents. This probably not only relates to differences of the biological behavior of human and rodent tumors, but also to the fact that regional lymph nodes of tumor patients are routinely examined during necropsies. Nevertheless, some doubts about the reliability of human mortality statistics also exist (24). To give an example, diagnoses on 68,772 death certificates of cancer patients did not agree with the registry diagnoses of the Ontario Cancer Registry in up to 20% of.the cases as regards various cancer types (21) . How can the assessment of the causes of death be improved? There is no doubt that at present the system is relatively crude and needs refinement. Newer tools such as computer tomography, ultrasound investigations, and nuclear magnetic resonance make it possible to follow the growth of neoplastic lesions and their regression after withdrawal of certain stimuli, thus helping to determine the biological behavior of tumors. Cell culture techniques and transplantation assays, cell kinetic analysis, and other modern histopathological tools provide further insight into the proliferative capacity of tissues and molecular processes such as expression of certain epitopes including oncogenes (6, 7).
How useful is the assessment of the causes of death? As stated in the Introduction, cause-of-death assessment is necessary as a basis for certain statistical procedures, the discussion ofwhich is not within the scope of this article. Cause-of-death assessment also compels pathologists to view an animal as 1 organism, to rate the severity of major lesions in more detail, and to come to a final conclusion. This might enable them to better understand the biological significance of lesions. Training pathologists in cause-of-death assessment would be an important step to further improve the evaluation of long-term animal studies.
Is cause-of-death assessment helpful for risk and safety assessment? At present probably not, as from the regulatory point of view it generally only matters whether an induced lesion is reversible or not and whether or not there is a no-toxic-effect level. In the latter case, whether a lesion is persistent, and therefore possibly not fatal, or progressive, and therefore. possibly finally fatal, is generally not taken into ac- (1 1-28)
Only calculated for 3 and more cases.
count in risk assessment. However, as more is learned about the biological behavior of lesions and their significance for humans, it is probable that in the future it will be important to know whether or not a lesion observed in a carcinogenicity study is fatal or not. A chemical with a potential to induce histologically and biologically benign tumors such as subcutaneous lipomas or uterine myomas might be rated less dangerous than a chemical inducing histologically and/or biologically malignant tumors such as carcinomas of the gastrointestinal tract or the central nervous system: In their retrospective study on National Toxicology Program data, Gold et al (10) found that chemicals that produce fatal tumors in rodents are more likely than other chemicals to induce tumors in both rats and mice, in both sexes, and at multiple sites.
colored nodules within the parenchyma or protruding from the pleural surface. The masses can be single or multiple, and the sizes range from 3 to 19 mm (see Table XII ).
Microscopically, the nodules are generally malignant bronchiolo-alveoloar neoplasms with evidence of local infiltration into surrounding parenchyma and/or other structures. Distant metastasis are relatively rare (seen in 12% of lung neoplasms in NMRI mice).
Coinnient. Death or a moribund state of an animal is due to reduction of the respiratory epithelium. It is therefore evident that size is more important than degree of malignancy in determining the likelihood of a tumor causing death.
ll~oiise-~~anritiary Gland Tiirtiors
In-Life. Readily palpable tumors. Pathology. Macroscopically, well-circumscribed nodular masses of 14-30 mm (maximum dimension; see also Table XII ). Microscopically, the tumors are adenoacanthomas with glandular and epidermoid differentiation. Metastases to the lungs occur in approximately 28% of female NMRI mice with mammary gland tumors.
Cormrent. Malignant mammary tumors cause death by local invasion and metastatic spread. They are rare in females and not found in males (see Table  XIII ).
Mouse-CGP
In-Lfe. Usually slow deterioration of bodily condition but some animals gain body weight with progressive abdominal distention, sometimes associated with skin edema.
Pathology. Macroscbpically, kidneys are discolored and shrunken and the cut surfaces reveal numerous small cysts.
Microscopically, "end-stage" kidney with glomerular hyalinization (sclerosis), tubular dilation, and interstitial inflammation.
Coninleiit. The diagnosis of cause of death due to renal failure is based primarily on the appearance of the "end-stage'' kidney.
Moiise-Skirt Ulceratioii
Zti-Life. Skin necrosis and ulceration are usually noted in the headheck region and are more common in females than in males (see Table XV ). The size of the lesions varies from 6 to 28 mm (see also Table XVII) .
Pathology. Microscopically, extensive areas of epidermal necrosis with acute dermal inflammation and overlying scab formation.
Cowtient. Mice with large and persistent skin lesions are killed on humane grounds. The lesion per se does not cause death. Small lesions may heal spontaneously. Etiologic agents have not been detected. Ectoparasites, pathogenic fungi, and bacteria have been reported to cause similar lesions in mice (8) .
